Evidence map›Paper›PMID 28031858›Full record

ReviewJournal of clinical movement disorders2016

Medical treatment of dystonia.

Pichet Termsarasab, Thananan Thammongkolchai, Steven J Frucht

Erratum issuedAbstract readReview
In one paragraph

Review in Journal of clinical movement disorders, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 39 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
39citing papers in PubMed, 2 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

39 citing papers in PubMed, 2 syntheses or guidelines pooled it.

  1. Managing Dystonia in Partington Syndrome.Movement disorders clinical practice · 2026
    Pooled it
  2. Pooled it
  3. A scoping review about the efficacy of clonazepam for the treatment of benign essential blepharospasm.Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology · 2026
    Article
  4. Brain-Computer Interface Improves Symptoms of Isolated Focal Laryngeal Dystonia: A Single-Blind Study.Movement disorders : official journal of the Movement Disorder Society · 2026
    Article
  5. Article
  6. Factors influencing botulinum toxin response in cervical dystonia: a two-center GAS-based study.Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology · 2026
    Observational
  7. Article
  8. Review
  9. Article
  10. Article
  11. Article
  12. Review
  13. Impact of Physiotherapy in the Treatment of Pain in Cervical Dystonia.Tremor and other hyperkinetic movements (New York, N.Y.) · 2024
    Article
  14. Basis of movement control in dystonia and why botulinum toxin should influence it?Toxicon : official journal of the International Society on Toxinology · 2024
    Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Brain-Computer Interfaces for Treatment of Focal Dystonia.Movement disorders : official journal of the Movement Disorder Society · 2022
    Article
  20. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

3 authors.

Pichet TermsarasabMovement Disorder Division, Department of Neurology, Icahn School of Medicine at Mount Sinai, New York, USA.ORCID 0000-0002-3260-3119
Thananan ThammongkolchaiDepartment of Neurology, University Hospitals Cleveland Medical Center, Cleveland, USA.
Steven J FruchtMovement Disorder Division, Department of Neurology, Icahn School of Medicine at Mount Sinai, New York, USA.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Therapeutic strategies in dystonia have evolved considerably in the past few decades. Three major treatment modalities include oral medications, botulinum toxin injections and surgical therapies, particularly deep brain stimulation. Although there has been a tremendous interest in the later two modalities, there are relatively few recent reviews of oral treatment. We review the medical treatment of dystonia, focusing on three major neurotransmitter systems: cholinergic, GABAergic and dopaminergic. We also provide a practical guide to medication selection, therapeutic strategy and unmet needs.

Indexed as

AnticholinergicBaclofenClonazepamDystoniaMedicationsPharmacologyTreatment

Identifiers

PMID28031858
PMCPMC5168853

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.